Russell Investments Group
PACB icon

Russell Investments Group’s Pacific Biosciences PACB Stock Holding History

Russell Investments Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
596,843
+126,968
+27% +$185K ﹤0.01% 2463
2026
Q1 		$620K Buy
469,875
+445,975
+1,866% +$798K ﹤0.01% 2423
2025
Q4 		$44.7K Buy
23,900
+1,029
+4% +$1.98K ﹤0.01% 3345
2025
Q3 		$29.3K Buy
+22,871
New +$31K ﹤0.01% 3475
2025
Q1 		– Sell
-5,057
Closed -$9.25K – 3859
2024
Q4 		$9.25K Buy
5,057
+148
+3% +$289 ﹤0.01% 3154
2024
Q3 		$8.35K Sell
4,909
-114,613
-96% -$188K ﹤0.01% 3125
2024
Q2 		$164K Buy
119,522
+10,936
+10% +$22.1K ﹤0.01% 2533
2024
Q1 		$407K Buy
108,586
+4,443
+4% +$26K ﹤0.01% 2264
2023
Q4 		$1.02M Buy
104,143
+9,998
+11% +$81.8K ﹤0.01% 1959
2023
Q3 		$786K Buy
94,145
+93,327
+11,409% +$1.07M ﹤0.01% 2045
2023
Q2 		$10.9K Hold
818
– – ﹤0.01% 2951
2023
Q1 		$9.47K Buy
+818
New +$8.13K ﹤0.01% 2891
2022
Q2 		– Sell
-793
Closed -$7K – 2949
2022
Q1 		$7K Sell
793
-98,099
-99% -$1.13M ﹤0.01% 2723
2021
Q4 		$2.02M Sell
98,892
-3,345
-3% -$80.7K ﹤0.01% 1796
2021
Q3 		$2.61M Sell
102,237
-22,913
-18% -$679K ﹤0.01% 1672
2021
Q2 		$4.37M Sell
125,150
-285,697
-70% -$8.31M 0.01% 1439
2021
Q1 		$13.7M Buy
410,847
+81,859
+25% +$2.87M 0.02% 776
2020
Q4 		$8.53M Buy
+328,988
New +$5.59M 0.02% 942
2020
Q3 		– Sell
-7,859
Closed -$27K – 3232
2020
Q2 		$27K Buy
+7,859
New +$26.8K ﹤0.01% 3033
2017
Q1 		– Sell
-407,395
Closed -$1.56M – 3050
2016
Q4 		$1.56M Buy
+407,395
New +$2.96M ﹤0.01% 1942

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Russell Investments Group's PACB Position: Q2 2026 in Review

Russell Investments Group increased its Pacific Biosciences (PACB) stake by 27% in Q2 2026, buying an estimated $185K and bringing the position to 596,843 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2463.

Russell Investments Group first reported a position in PACB in Q4 2016 and has held it in 20 quarters since. The position peaked at $13.7M in Q1 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Russell Investments Group held 596,843 shares of Pacific Biosciences worth $1M as of Q2 2026.
  • Russell Investments Group bought 126,968 Pacific Biosciences shares in Q2 2026, an estimated $185K.
  • Pacific Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2463 holding.
  • Russell Investments Group first reported a position in Pacific Biosciences in Q4 2016 and has held it in 20 quarters since.
  • Russell Investments Group's Pacific Biosciences position peaked at $13.7M in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.